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Minhthy Meineke, Richard L Applegate II*, Thomas Rasmussen, Donald Anderson, Sherif Azer, Ali Mehdizadeh,
Amy Kim and Martin AllardAbstract
As life expectancy increases, more patients ≥65 years undergo general anesthesia. Anesthetic agents may contribute
to postoperative cognitive dysfunction, and incidence may differ with anesthetic agents or intraoperative anesthesia
depth. Responses to anesthetic adjuvants vary among elderly patients. Processed electroencephalography guidance
of anesthetic may better ensure equivalent cerebral suppression. This study investigates postoperative cognitive
dysfunction differences in elderly patients given desflurane or sevoflurane using processed electroencephalography
guidance.
IRB approved, randomized trial enrolled consenting patients ≥65 years scheduled for elective surgery requiring
general anesthesia ≥120 minute duration. After written informed consent, patients were randomly assigned to
sevoflurane or desflurane. No perioperative benzodiazepines were administered. Cognitive impairment was measured
by an investigator blinded to group assignment using mini-Mental Status Examination (MMSE) at baseline; 1, 6, and
24 hours after the end of anesthesia. Mean arterial pressure was maintained within 20% of baseline. Anesthetic dose
was adjusted to maintain moderate general anesthesia per processed electroencephalograpy (Patient State Index
25 to 50). The primary outcome measure was intergroup difference in MMSE change 1 hour after anesthesia (median;
95% confidence interval).
110 patients consented; 26 were not included for analysis (no general anesthesia; withdrew consent; baseline MMSE
abnormality; inability to perform postoperative MMSE; data capture failure); 47 sevoflurane and 37 desflurane were
analyzed. There were no significant differences in patient characteristics; intraoperative mean blood pressure
(desflurane 86.4; 81.3 to 89.6 versus sevoflurane 82.5; 80.2 to 86.1 mmHg; p = 0.42) or Patient State Index (desflurane
41.9; 39.0 to 44.0 versus sevoflurane 41.0; 37.5 to 44.0; p = 0.60) despite a lower MAC fraction in desflurane (0.82; 0.77
to 0.86) versus sevoflurane (0.96; 0.91 to 1.03; p < 0.001). MMSE decreased 1 hour after anesthesia (p < 0.001). The
decrease at one hour was larger in sevoflurane (−2.5; −3.3 to −1.8) than desflurane (−1.3; −2.2 to −0.5; p = 0.03).
MMSE returned to baseline by 6 hours after anesthesia.
Conclusions: For elderly patients in whom depth of anesthesia is maintained in the moderate range, both desflurane
and sevoflurane are associated with transient decreases in cognitive function as measured by MMSE after anesthesia,
with clinically insignificant differences between them in this setting.
Trial registry: ClinicalTrials.gov NCT01199913
Keywords: General anesthesia, Postoperative cognitive decline, Geriatric patient* Correspondence: rapplegate@llu.edu
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As life expectancy increases, an increasing portion of
patients who undergo procedures involving general
anesthesia are ≥65 years [1]. It is estimated that in 2012
the population >65 years represented 16% of the more
developed nations [2], and by 2025 this age group will
represent 21% of the industrialized population [3]. Post-
operative cognitive decline or dysfunction (POCD) may
occur after general anesthesia [4], and the risk of devel-
oping dementia in the subsequent 3 to 7 years following
anesthesia and surgery is reported to be nearly doubled
in elderly patients who develop POCD [5]. POCD at hos-
pital discharge has been associated with greater mortality
in the first 3 months and 1 year following surgery [4].
The type and severity of dysfunction may evolve over
time [6]. Further, in patients >60 years, some types of
postoperative cognitive dysfunction such as delirium may
predict worsening cognitive function in the first year after
surgery [7].
The cognitive sequelae after anesthesia with desflurane
or sevoflurane deserve further investigation. Both agents
have low blood-gas partition coefficients, allowing for
shorter induction times compared to more soluble inhaled
anesthetics. Some differences between the two agents have
been reported, including a shorter emergence time follow-
ing desflurane than sevoflurane anesthesia. While some
investigators report similar POCD incidence [8], others
have implicated sevoflurane in the development of mild
cognitive impairment [9].
Anesthetic administration has been guided by use of
age-adjusted estimations of minimum alveolar concen-
trations (MAC) [10,11], the concentration at which 50%
of patients will not move in response to surgical incision
[12]. MAC fraction is the ratio of anesthetic concentra-
tion divided by MAC for the specific agent, and is used
to facilitate assessment of clinical differences between
inhaled anesthetics [13]. The immobilizing effect of in-
haled anesthetics is primarily mediated at the spinal cord
level [14-16], although concentrations approaching 3 MAC
will produce immobility when isolated brain anesthetic
delivery is done in animals [17]. However, contemporary
general anesthetic techniques include the use of neuro-
muscular blocking drugs that markedly reduce clinicians’
ability to use movement in response to incision as a guide
to adequate anesthetic depth, and include addition of
opioids or other anesthetic adjuvants to inhaled anes-
thetics. Increased sensitivity to drugs is common in eld-
erly patients [18-20], and interindividual variability in
drug responses results in differing sensitivity. These fac-
tors make predicting precise doses difficult [21], particu-
larly for sedative, opioid and anesthetic drugs since
physiologic function varies between patients of similar age
[20,22]. It follows that when adjuvant drugs are added,
the degree of cerebral suppression induced by controllinginhaled anesthesia depth using age-adjusted MAC could
vary between patients.
Older patients given inhaled anesthetics require a lower
MAC fraction to produce an equivalent degree of cerebral
suppression measured by processed EEG [23]. If greater
intraoperative cerebral suppression (deep anesthesia) is
related to POCD, then assessing the impact of inhaled
agents may be better done when equivalent degrees of
cerebral suppression are maintained, rather than using
equivalent estimations of anesthetic effect calculated from
end-tidal anesthetic agent concentration. Several investi-
gations have reported processed electroencephalogram
(EEG) use to guide anesthesia administration in POCD
study patients. Patients who had fewer episodes of deep
anesthesia detected by processed EEG had less postop-
erative delirium [24], while patients in whom combined
processed EEG and regional cerebral oximetry remained
in moderate target ranges had less POCD [25]. Transi-
ent POCD was found in nearly half of elderly patients
given desflurane or sevoflurane titrated to light general
anesthesia as guided by processed (EEG) [26]. Of note,
light general anesthesia may be associated with undesir-
able cardiovascular effects. This study was designed to
investigate POCD differences between desflurane and
sevoflurane in elderly patients in whom cerebral suppres-
sion is maintained in a moderate general anesthesia range
guided by processed EEG.
Methods
The Institutional Review Board of Loma Linda University
approved this randomized controlled trial, which was
registered in ClinicalTrials.gov (NCT01199913). Writ-
ten informed consent was obtained from adult pa-
tients ≥65 years undergoing surgery requiring general
anesthesia scheduled for ≥120 minutes. American Society
of Anesthesiologists physical status and a measure of
physiologic comorbidity (P-POSSUM) [27,28] were re-
corded. Patients were excluded for clinically significant
cardiovascular, respiratory, hepatic, renal, neurological,
psychiatric or metabolic disease. This included any prior
history of cerebral vascular disease or dementia. Patients
were also excluded if they weighed more than 150% of
their ideal body weight (male: ideal body weight [in kg] =
50 + 2.3 kg per inch >5 feet; female ideal body weight
[in kg] = 45.5 + 2.3 k g per inch >5 feet). To ensure ability
to complete the cognitive function tests, patients who did
not speak English or did not have at least an elementary
school education were excluded from the study. Patients
who had undergone a general anesthetic within the past
7 days were also excluded.
After consenting, patients were assigned to either des-
flurane or sevoflurane by computerized random sequence
generator. Only the anesthesia provider was aware of the
patient’s group assignment. Clinicians were allowed to
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priate. The surgeons, nurses (operating room, recovery
room and postoperative unit), patients and other investi-
gators remained blinded to group assignment until study
participation was completed. No inducement was offered
for study participation. No preoperative sedation or peri-
operative benzodiazepine was given to patients. The risk
of increased anxiety from withholding preoperative sed-
ation was thoroughly discussed with patients during in-
formed consent. Additionally, patients were informed
they could request preoperative sedation and withdraw
consent at any time prior to anesthesia induction, with
subsequent exclusion from the study but no negative im-
pact on their perioperative care.
Subjects received general anesthesia using propofol
(2–2.5 mg/kg) for induction and the assigned inhaled
anesthetic in oxygen and air for maintenance. Anesthesia
delivery was titrated to the moderate general anesthesia
range based on processed EEG (Patient State Index 25–
50; SEDLine; Masimo, Irvine, CA, USA). Patients were
excluded if data capture of the PSI values to the anesthesia
record or internal storage drive on the processed EEG
device failed. Mean arterial pressure was kept within
20% of patient’s baseline value as determined on the
morning of surgery, with fluid and transfusion manage-
ment decisions left to the discretion of the anesthesia
provider. Ventilation was adjusted to maintain normo-
carbia (target end-tidal CO2 35 to 40 mmHg) and total
fresh gas flows were ≥ 2 l/min. The fraction of inspired
oxygen and use of positive end expiratory pressure (PEEP)
were determined by the anesthesia provider and adjusted
as necessary to maintain adequate oxygenation (pulse ox-
imeter saturation >92%). Intraoperative opioids were lim-
ited to fentanyl and hydromorphone. No morphine was
administered to limit the risk for mental clouding from ac-
tive morphine metabolites.
Patients were screened for cognitive impairment using
the Mini-Mental Status Examination (MMSE) adminis-
tered before and after the anesthetic. This screening test
quantitatively assesses cognitive impairment on a scale
from 0 to 30 (lower scores indicate worse impairment)
based on answers to a variety of questions [29], and is
suggested as one method to identify patients in whom
cognitive impairment is suspected [30]. The MMSE has
been reported to be a useful screening tool for POCD in
hospitalized elderly patients [31], and may identify pa-
tients at greater risk for delirium following cardiac sur-
gery [7]. Screening for cognitive impairment using the
MMSE has been suggested as a way to identify patients in
whom intervention could slow or halt the progression to
dementia [4]. Use of the MMSE to evaluate patients after
surgery under general anesthesia has been shown to be
both easy and reliable [25,26,31]. A decrease in MMSE > 2
points was deemed clinically significant [32-34].An investigator who was blinded to group assignment
obtained MMSE prior to patient transfer to the operat-
ing room (baseline). MMSE was obtained postopera-
tively 1, 6, and 24 hours after the end of anesthesia.
Patients were administered two versions of the MMSE,
to ensure the patient did not take the same version at
consecutive measurements to avoid a falsely elevated
MMSE score as a consequence of learning from the pre-
vious MMSE. The same investigator who was blinded to
group assignment obtained all MMSE for any patient.
End of anesthesia was defined as the time when the in-
haled agent was turned off and emergence time defined
as the time between anesthesia end and tracheal extuba-
tion. We preferentially enrolled patients whose proce-
dures were scheduled such that the MMSE 6 hours
after anesthesia would not be obtained after 10 PM to
minimize the impact of circadian rhythm on alertness.
Patients were removed from study participation if the
surgical procedure was not finished to allow administra-
tion of the MMSE 6 hours after anesthesia end prior to
10 PM as sleepiness can decrease MMSE score [35,36]
and patients would be expected to be tired or sleepy at
that time of day.
Verbal pain scores (ranging from 0 = no pain to 10 =
most severe pain imaginable) were obtained at baseline
and again before all MMSE administrations. Patients
only received fentanyl or hydromorphone in the posta-
nesthesia recovery room. The surgical team prescribed
all analgesic medications after patients’ discharge from
the recovery room. Opioids administered were converted
to morphine equivalents. Postoperative nausea and vomit-
ing was treated with ondansetron first, then if needed with
metoclopramide. Management of patients who required
further treatment for postoperative nausea and vomiting
was at the discretion of the anesthesia provider, but pa-
tients who received sedative antiemetics such as pro-
methazine prior to the MMSE one hour after anesthesia
end were excluded from analysis.
Statistical methods: Sample size was calculated based
on an intergroup difference of a least 2 points in MMSE
decrease at one hour with power set to 0.8 and p = 0.05
considered statistically significant. Based on this calcula-
tion, 84 patients needed to successfully complete study
participation to show statistical significance. Data ana-
lysis (JMP 10.0.0, SAS Institute, Cary, NC, USA) re-
vealed continuous data were not normally distributed
(Shapiro Wilk; all p < 0.05 indicated data were not nor-
mally distributed). Continuous data were analyzed by
Wilcoxon test and expressed as median, 95% confidence
interval. Repeated measurement data at the 4 measure-
ment points for MMSE, test times and pain scores were
analyzed by Friedman with Dunn’s multiple corrections
test. Categorical data were analyzed by Chi square. For
all analyses, p < 0.05 indicated statistical significance.
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ference in MMSE change at one hour after anesthesia
end. Secondary measures included intergroup differences
in demographic characteristics; calculated age-adjusted
MAC fraction based on end tidal anesthetic concentration
[10], emergence time (minutes); PACU time (minutes);
length of hospital stay (days); MMSE change over time;
and MMSE change one hour after anesthesia compared to
length of anesthesia.
Results
A total of 110 patients consented to participate and were
randomized between September 2010 and January 2012,
and 26 patients did not complete participation resulting
in 84 patients completing study participation. Anesthesia
providers changed group assignment resulting in 50
patients assigned to desflurane and 60 to sevoflurane.
Several patients were lost to follow up (CONSORT dia-
gram, Figure 1) leaving 37 desflurane and 47 sevoflurane
patients for analysis. There were no intergroup differences
in patient or perioperative characteristics (Table 1). The
average PSI during surgery was within the target range in
all patients, although 30 had PSI <25 for short periods of
time, with no intergroup differences, and no patient had
recorded PSI <25 for more than 10% of anesthesia time.
The average calculated age-adjusted end-tidal anesthetic
agent MAC fraction was lower in desflurane (0.82; 0.77 to
0.86 MAC) than sevoflurane (0.96; 0.91 to 1.03 MAC;
p < 0.0001) to attain a similar average PSI (desflurane
41.9; 39.0 to 43.8 versus sevoflurane 41.0; 37.5 to 44.0;
p = 0.60). The average age adjusted MAC did not correlateEnro
Allocated to Desflurane n = 55
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Figure 1 Consolidated Standards of Reporting Trials (CONSORT) flowto the average PSI overall (R2 < 0.01) or in desflurane
(p R2 = 0.05) or sevoflurane (R2 = 0.03) patients. All postop-
erative pain scores were higher than baseline regardless of
group (p < 0.0001), but decreased from 1 hour to 6 and
24 hours after anesthesia end (p < 0.01). However, there
were no significant intergroup differences in pain scores at
any time, or in total opioid administration (all p > 0.05).
There were no significant intergroup differences in other
secondary outcome measures (Table 1). Regression analysis
showed no relationship between the duration of anesthesia
and the change in MMSE one hour after anesthesia end
(R2 = 0.03).
There were no significant intergroup differences in
MMSE scores at any time point. MMSE one hour after
anesthesia decreased from baseline in both sevoflurane
and desflurane (p < 0.001; Figure 2). While the magnitude
of decrease was small, the change in MMSE one hour after
anesthesia was greater in sevoflurane (−2.5; −3.3 to −1.8)
than desflurane (−1.3; −2.2 to −0.5; p = 0.03; Figure 3), but
the difference between groups was not clinically significant
(not at least 2 points). MMSE one hour after anesthesia
was more likely to decrease from baseline in sevoflurane
(85.1%) than desflurane (62.2%; p = 0.02), and clinically sig-
nificant (at least 2 point) decrease was more likely in sevo-
flurane (68.1%) and desflurane (46.0%; p = 0.04; Table 2).
Three patients were discharged prior to obtaining the
MMSE 6 hours after anesthesia and an additional 3 were
discharged prior to obtaining the MMSE 24 hours after
anesthesia. Analysis of the remaining patients showed
that MMSE was not significantly different either be-
tween groups or from baseline at 6 or 24 hours. Testinglled n = 110
mized n = 110
Allocated to Sevoflurane n = 55
Received allocated intervention n = 56
   + Clinician reassigned from Desflurane 
(n=5)
   - Local or regional anesthesia (n=3)
   - Consent withdrawn (n=1)
   - Abnormal baseline MMSE (n=1)
Lost to follow up n = 3
   - Unable to obtain 6 hour MMSE prior to 
           10 PM (n=1)
   - Comorbid condition prevented MMSE 
            (n=1)
   - Withdrew consent after surgery (n=1)
Analyzed n = 47
Excluded from analysis n = 5
  - Data capture failure (n=2)
  - Sedative medication in recovery room (n=3)
     [midazolam; morphine; promethazine; n=1 each]
diagram.
Table 1 Patient and perioperative characteristics
Desflurane n = 37 Sevoflurane n = 47 p-value
Patient characteristics
Age years 72.3; 69.8 to 74.4 71.9; 70.1 to 73.6 0.96
Gender # female, male 24, 13 33, 14 0.60
Body mass index kg/m2 26.3; 25.3 to 27.6 26.6; 25.3 to 27.6 0.99
P-POSSUM physiology score 19.8; 17.4 to 21.7 19.1; 17.4 to 21.6 0.40
ASA physical status # 2, 3, 4 14, 23, 0 23, 22, 2 0.22
Comorbid conditions # (%) with
Hypertension 26 (70.3%) 33 (70.2%) 0.99
Cardiovascular disease 5 (13.5%) 10 (21.3%) 0.36
Diabetes mellitus 7 (18.9%) 6 (12.8%) 0.44
Renal disease 4 (10.8%) 3 (6.4%) 0.47
Pulmonary disease 2 (5.4%) 8 (17.0%) 0.10
Preadmission medications # (%) taking
Opioid 1 (2.7%) 0 0.26
Antihypertensive 26 (70.3%) 31 (66.0%) 0.67
Cardiac 3 (8.1%) 1 (2.1%) 0.20
Antihyperglycemic 6 (16.2%) 6 (12.8%) 0.65
Respiratory 1 (2.7%) 7 (14.9%) 0.06
Hypnotic 1 (2.7%) 0 0.26
Type of procedure performed # (%) 0.27
Intra-abdominal 3 (8.1%) 4 (8.5%)
Other general surgery 1 (2.7%) 3 (6.4%)
Pelvic (gynecologic or urologic) 27 (73.0%) 25 (53.2%)
Orthopedic 6 (16.2%) 15 (31.9%)
Intraoperative characteristics
Average patient state index 41.9; 39.0 to 43.8 41.0; 37.5 to 44.0 0.60
Average age adjusted anesthetic minimum alveolar concentration fraction% 0.82; 0.77 to 0.86 0.96; 0.91 to 1.03 <0.0001
Mean arterial blood pressure mmHg 86.4; 81.3 to 89.6 82.5; 80.2 to 86.1 0.42
Mean arterial blood pressure change from preoperative baseline blood pressure % −5.7; −10.7 to −0.7% −9.2; −14.0 to −4.9% 0.18
End tidal carbon dioxide mmHg 33.6; 33.1 to 34.6 33.2; 32.7 to 33.6 0.28
Pulse oxygen saturation % 98.4; 98.0 to 99.0 98.6; 9.1 to 99.0 0.67
Anesthesia time minutes 144; 119 to 170 139; 125 to 157 0.89
Surgery time minutes 118; 92 to 148 119; 108 to 133 0.60
Emergence time minutes 7.7; 6.3 to 9.1 8.2; 6.9 to 9.6 0.51
Cough on tracheal extubation # (%) yes 8 (21.6%) 12 (25.5%) 0.68
Opioid morphine equivalents mcg/kg/hour 116.1; 91.1 to 151.2 143.2; 110.3 to 165.4 0.35
Postoperative Characteristics
Recovery room opioids morphine equivalents mcg/kg 99.3; 54.7 to 144.6 101.6; 78.9 to 145.6 0.44
Postoperative nausea / vomiting # yes 18 (48.7%) 17 (36.2%) 0.25
Recovery room length of stay minutes 105; 96 to 114 102; 91 to 114 0.74
Hospital length of stay, days 1.6; 1.1 to 2.0 1.4; 1.2 to 2.0 0.63
Table 1: There were no significant intergroup differences in patient and perioperative characteristics of 84 patients anesthetized with either desflurane or sevoflurane.
Continuous data were not normally distributed (Shapiro Wilk p < 0.05) and were expressed as median, 95% confidence interval and analyzed by Wilcoxon. Categorical
data were analyzed by Chi square.
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Figure 2 Comparison of Mini Mental State Exam (MMSE) scores
in patients given desflurane (n = 37) or sevoflurane (n = 47)
anesthesia, numbers indicate median and 95% confidence
interval. The MMSE was lower one hour after anesthesia for both
groups (p < 0.001 Wilcoxon matched pairs). The MMSE scores were
equal to baseline at 6 and 24 hours after the end of anesthesia, and
there were no intergroup differences in MMSE scores at any
measurement time (all p > 0.05, Friedman with Dunn’s multiple
corrections test).
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Figure 3 Change in Mini Mental Status Exam (MMSE) score one
hour after the end of anesthesia, numbers indicate median,
95% confidence interval. Although the MMSE score decreased
more in the 47 patients anesthetized with sevoflurane (−2.4, −3.2
to −1.7) than in the 37 patients anesthetized with desflurane (−1.3; −2.3
to −0.5; p = 0.04 Wilcoxon), the difference in the magnitude of decrease
was not clinically significant (not at least 2 points).
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7.5 minutes) compared to baseline (5.1; 4.9 to 5.3 minutes;
p < 0.0001), but was the same as baseline 6 and 24 hours
after anesthesia. Testing time was not different between
groups at any point.
Discussion
We were not able to demonstrate a clinically significant
(at least 2 point) difference in MMSE one hour after
anesthesia end in patients ≥65 years given sevoflurane
compared to desflurane titrated to moderate general
anesthesia guided by processed EEG (PSI 25 to 50). Des-
pite the slightly greater likelihood of MMSE decrease
one hour after anesthesia in sevoflurane, we were not
able to show an intergroup difference of at least 2 points.Further, the small decrease found at one hour was no lon-
ger present and MMSE had returned to baseline by 6 hours
after anesthesia. Thus, our results show only a minimal
transient decrease in cognitive function assessed by MMSE
one hour after anesthesia with no clinically significant dif-
ference between sevoflurane and desflurane when adminis-
tered as in this setting.
These findings are similar to those found in elderly pa-
tients in whom the inhalation agent was titrated to light
general anesthesia guided by processed EEG (bispectral
index 55 to 65) [26]. However, the average MMSE de-
crease reported in that study was <2 points for both
sevoflurane and desflurane, and the proportion who had
at least 2 point decrease was not reported. A subgroup
analysis revealed more POCD when patients had more
intraoperative episodes of deep anesthesia indicated by
processed EEG monitoring [24]. POCD was less frequent
in elderly patients when moderate anesthesia depth was
maintained using processed EEG guidance compared
to routine care based on clinical signs and end-tidal
anesthetic agent concentration [37]. The use of processed
EEG guidance was associated with less anesthetic agent
delivery, but no comparison of inhaled agents was pro-
vided. Studies in which anesthesia administration was
guided by inspired or end-tidal anesthetic concentration
and age-adjusted estimations of minimum alveolar con-
centrations (MAC) could be confounded by the impact
of drug co-administration. The presence of interindivid-
ual variability in response to opioids and the variable
effects of aging on pharmacodynamics, suggest that ti-
trating anesthesia depth based solely on age-adjusted
MAC could result in different degrees of cerebral sup-
pression. We titrated inhaled anesthetics to the processed
Table 2 Comparison of mental status examination scores
Desflurane n = 37 Sevoflurane n = 47 p-value
MMSE baseline (n = 84) 29.1 29.0 0.63
28.6 to 29.5 28.3 to 29.5
MMSE 1 hour after anesthesia (n = 84) 27.5 26.7 0.07
26.5 to 28.3 25.6 to 27.4
Change in MMSE at 1 hour (n = 84) −1.3 −2.5 0.03
−2.2 to −0.5 −3.3 to −1.8
MMSE decreased at 1 hour # (%) yes 23 (62.2%) 40 (85.1%) 0.02
MMSE decrease at least 2 points 1 hour after anesthesia end # (%) yes 17 (46.0%) 32 (68.1%) 0.04
MMSE 6 hours after anesthesia (n = 81) 28.9 29.2 0.70
28.5 to 29.4 28.5 to 29.7
MMSE 24 hours after anesthesia (n = 78) 28.9 29.2 0.39
28.3 to 29.3 28.3 to 29.7
Table 2: Mini Mental Status Exam (MMSE) scores in patients anesthetized with sevoflurane or desflurane. Continuous data are presented as median, 95%
confidence interval and were analyzed by Wilcoxon; categorical data were analyzed by Chi square. Three patients were discharged prior to obtaining the MMSE
6 hours after anesthesia and an additional 3 were discharged prior to obtaining the MMSE 24 hours after anesthesia. The MMSE was not significantly different
between groups at any measurement time. While the MMSE obtained one hour after anesthesia end was more likely to decrease from baseline in sevoflurane
than desflurane, this difference was less than considered clinically significant (not at least 2 points) and was not present at 6 or 24 hours after anesthesia.
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than sevoflurane. Although this study was not designed
to investigate the relationship between end-tidal anesthetic
agent concentration and processed EEG values, the lower
MAC fraction in desflurane is consistent with studies dem-
onstrating lower processed EEG values at 1 MAC in des-
flurane compared to sevoflurane anesthetized patients [38].
Thus titration to similar processed EEG values would be
expected to require a lower MAC fraction for desflurane
than sevoflurane. Assessing the contribution of anesthetic
agents to postoperative cognitive impairment could thus
be confounded by greater intraoperative cerebral suppres-
sion (deep anesthesia) at the calculated age-adjusted MAC.
It would seem prudent to include equivalent degrees of
cerebral suppression rather than estimations of anesthetic
effect when comparing postoperative cognitive effects of
specific anesthetic agents.
Several factors limit generalization of our findings to
other settings. Importantly, fewer patients received des-
flurane than sevoflurane based on changing group as-
signment by individual clinical anesthesiologists, typically
for concerns about airway reactivity. Reallocation was
allowed in the protocol as our research community con-
sidered this to be important for patient safety. It is pos-
sible that the clinician could have been subtly influenced
to choose one agent over the other, but despite this we
found no significant differences in patient or periopera-
tive characteristics. The clinical anesthesiologists did not
obtain MMSE scores for any patient. Further, we found
no intergroup differences in intraoperative opioid admin-
istration but did find similar depth of anesthesia as mea-
sured by processed EEG. Thus it is unlikely that patientreallocation by clinicians significantly impacted any dif-
ferences in MMSE. Another limitation is that pain in-
creased from baseline to the time MMSE was obtained
one hour after anesthesia end. It is possible that in-
creased pain itself contributed to lower MMSE scores at
that time. However, we did not find intergroup differ-
ences in either verbal pain scores or the change in pain
score from baseline at this or other times that MMSE
was obtained and opioid administration was similar in
the groups. Thus while the decrease in MMSE one hour
after anesthesia end may have been partly caused by in-
creased pain, the slightly greater magnitude of MMSE
decrease in sevoflurane is not likely based solely on pain.
We chose to perform analysis based on the agents as ad-
ministered since we were concerned about the clinical ef-
fects of the agents.
We used the MMSE to screen for cognitive dysfunc-
tion instead of more complete testing panels as some
have used [39-41], which may also limit generalization
of our findings. While the MMSE may require more
time to complete than some consider ideal, it can detect
cognitive impairment in elderly patients, as suggested
ideal for preoperative screening [42]. Additionally the
MMSE has been used in a wide range of clinical settings,
including in elderly surgical patients [25,26,31], which
makes it a reasonable screening tool. The greater sensi-
tivity of more extensive testing panels is associated with
a longer test time, which elderly patients may not be
willing to perform in the immediate postoperative period.
The MMSE has high specificity for detecting mild cogni-
tive impairment [43], and was thus chosen for use in
our study setting. Six of the 9 patients lost to follow up
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surgery taking longer than scheduled, which would have
resulted in MMSE testing at late times of the day. Re-
moval of these patients could have impacted the small
intergroup difference we found at one hour. The choice
to not complete the study on these patients was deemed
appropriate since sleepiness has been associated with
lower MMSE score [35,36]. Several patients were dis-
charged prior to obtaining the MMSE at 6 and 24 hours
after anesthesia, which could confound comparisons at
those times, although it is likely that patients deemed
ready for discharge would have MMSE similar to their
baseline. Exclusion of these 6 patients did not alter re-
sults for the intergroup difference in MMSE change from
baseline one hour after anesthesia. Only 9 of our patients
were ≥80 years old. This small number prevents us from
detecting any difference between sevoflurane and desflur-
ane in very old patients. Few patients had significant dur-
ation of low PSI, which limits our ability to assess a
possible impact of deep anesthesia on change in MMSE.
This is to be expected since the protocol specified titra-
tion of inhaled agents to moderate general anesthesia as
guided by processed EEG. However, our findings suggest
processed EEG monitoring can be successfully used to
guide titration of inhaled anesthetic dosing in the elderly.Conclusions
In patients ≥65 years old, administration of desflurane or
sevoflurane titrated to moderate general anesthesia as
guided by processed EEG (PSI 25 to 50) was not associ-
ated with a lasting decrease in MMSE of at least 2 points.
Our finding of only a slightly larger transient decrease in
cognitive performance following sevoflurane compared to
desflurane suggests either may be acceptable for geriatric
patients when titrated to moderate general anesthesia.
Further research is warranted to determine if the effects of
these agents would differ when titrated to deep general
anesthesia as indicated by processed EEG.
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